NCT02170909View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2005

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS low dose

DRUG

BIBR 1048 MS medium dose

DRUG

BIBR 1048 MS high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170909 - Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin | Biotech Hunter | Biotech Hunter